CYCC logo

Cyclacel Pharmaceuticals (CYCC) Company Overview

Profile

Full Name:

Cyclacel Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 16, 2004

Indexes:

Not included

Description:

Cyclacel Pharmaceuticals is a biotechnology company focused on developing innovative cancer therapies. They specialize in cell cycle regulation and aim to create treatments that target cancer cells while minimizing harm to healthy cells. Their research includes novel drugs and clinical trials to improve patient outcomes.

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 18, 2023

Analyst ratings

Recent major analysts updates

May 3, 24 Roth MKM
Buy
Dec 19, 23 Roth MKM
Buy
Dec 19, 23 Brookline Capital
Hold
May 25, 23 Oppenheimer
Outperform
Mar 7, 23 Oppenheimer
Outperform
Apr 30, 21 Oppenheimer
Outperform
Nov 25, 20 Roth Capital
Buy
Nov 25, 20 JMP Securities
Market Outperform
Nov 25, 20 H.C. Wainwright
Buy
Sep 5, 18 Roth Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cyclacel Pharmaceuticals?
  • Does Cyclacel Pharmaceuticals pay dividends?
  • What sector is Cyclacel Pharmaceuticals in?
  • What industry is Cyclacel Pharmaceuticals in?
  • What country is Cyclacel Pharmaceuticals based in?
  • When did Cyclacel Pharmaceuticals go public?
  • Is Cyclacel Pharmaceuticals in the S&P 500?
  • Is Cyclacel Pharmaceuticals in the NASDAQ 100?
  • Is Cyclacel Pharmaceuticals in the Dow Jones?
  • When was Cyclacel Pharmaceuticals's last earnings report?
  • When does Cyclacel Pharmaceuticals report earnings?
  • Should I buy Cyclacel Pharmaceuticals stock now?

What is the ticker symbol for Cyclacel Pharmaceuticals?

The ticker symbol for Cyclacel Pharmaceuticals is NASDAQ:CYCC

Does Cyclacel Pharmaceuticals pay dividends?

No, Cyclacel Pharmaceuticals does not pay dividends

What sector is Cyclacel Pharmaceuticals in?

Cyclacel Pharmaceuticals is in the Healthcare sector

What industry is Cyclacel Pharmaceuticals in?

Cyclacel Pharmaceuticals is in the Biotechnology industry

What country is Cyclacel Pharmaceuticals based in?

Cyclacel Pharmaceuticals is headquartered in United States

When did Cyclacel Pharmaceuticals go public?

Cyclacel Pharmaceuticals's initial public offering (IPO) was on March 16, 2004

Is Cyclacel Pharmaceuticals in the S&P 500?

No, Cyclacel Pharmaceuticals is not included in the S&P 500 index

Is Cyclacel Pharmaceuticals in the NASDAQ 100?

No, Cyclacel Pharmaceuticals is not included in the NASDAQ 100 index

Is Cyclacel Pharmaceuticals in the Dow Jones?

No, Cyclacel Pharmaceuticals is not included in the Dow Jones index

When was Cyclacel Pharmaceuticals's last earnings report?

Cyclacel Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Cyclacel Pharmaceuticals report earnings?

The next expected earnings date for Cyclacel Pharmaceuticals is Mar 19, 2025

Should I buy Cyclacel Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions